首页 | 本学科首页   官方微博 | 高级检索  
检索        

抑制MTAl对雌二醇调控ER阳性乳腺癌细胞MMP-9、TIMP-1表达的影响
引用本文:王晶,;于航,;王鹏,;谢长英,;倪秀芹.抑制MTAl对雌二醇调控ER阳性乳腺癌细胞MMP-9、TIMP-1表达的影响[J].实用肿瘤学杂志,2014(6):503-507.
作者姓名:王晶  ;于航  ;王鹏  ;谢长英  ;倪秀芹
作者单位:[1]哈尔滨医科大学大庆校区生理教研室,大庆163319; [2]大庆油田总医院肾内科;,大庆163319; [3]哈尔滨医科大学大庆校区解剖教研室,大庆163319;
基金项目:黑龙江省科技厅科技攻关项目(GC09C406-4)
摘    要:目的:观察转移相关蛋白1( Metastasis associated protein 1,MTA1)在雌激素调控雌激素受体(Estrogen Recepto,ER)阳性乳腺癌细胞基质金属蛋白酶-9(Matrix metalloproteinase -9,MMP-9)、基质金属蛋白酶组织抑制因子( Tissue inhibitor of metalprotease -1,TIMP-1)中的可能作用。方法采用慢病毒转染MTA1-shRNA的方法建立特异性抑制MTA1表达的MCF-7模式细胞株。采用10 nM雌二醇(17β-estradiol,E2)处理细胞48 h,Real-time PCR、Western blot分别检测MMP-9、TIMP-1 mRNA与蛋白表达。结果 MTA1-shRNA最大抑制效率为84.9%,提示成功建立了抑制MTA1表达的MCF-7模式细胞株(MCF-7MTA1-shRNA)。 MCF-7野生株(MCF-7WT)在E2处理后MMP-9 mRNA和蛋白表达水平分别上升了46%(P<0.05)和37%(P<0.05),TIMP-1 mRNA和蛋白表达水平分别降低了32.3%(P<0.05)和18.2%(P<0.05);相对MCF-7WT,MCF-7MTA1-shRNA MMP-9 mRNA和蛋白表达水平分别降低了42.9%(P<0.05)和36.7%(P<0.05),TIMP-1 mRNA和蛋白表达水平未见显著变化;采用E2处理MCF-7MTA1-shRNA后,MMP-9 mRNA和蛋白表达水平未见明显变化,TIMP-1 mRNA和蛋白表达水平分别降低了25.4%(P<0.05)和32.2%(P<0.05)。结论 MTA1在雌激素上调ER阳性乳腺癌细胞MMP-9表达的信号转导通路中可能发挥重要作用,但未参与雌激素调控ER阳性乳腺癌细胞TIMP-1表达的信号转导通路。

关 键 词:乳腺癌  雌激素  转移相关蛋白1  基质金属蛋白酶-9  金属蛋白酶组织抑制因子-1

Study on the role of MAT1 in estradiol regulated MMP- 9, TIMP - 1 expression in ER positive breast cancer
Institution:WANG Jing , YU Hang WANG Peng ,XIE Changymg ,NI Xiuqin( 1. Department of Physiology, Harbin Medical University- Daqing, Daqing 163319, China ;2. Department of Neph- rology, Daqing Oilfield General Hospital;3. Department of Anatomy, Harbin Medical University -Daqing)
Abstract:Obej ctive To investigate the role of metastasis associated protein 1(MTA1)in estrogen reg-ulated expression of matrix metalloproteinase -9(MMP-9)and tissue inhibitor of metalprotease -1(TIMP-1) in estrogen receptor( ER ) positive breast cancer cells .Methods MTA1 knockdown cell model was generated based on MCF-7breast cancer cell line by transfected with MTA 1-shRNA.The mRNA and protein level of MMP-9 and TIMP-1 in wild type MCF-7(MCF-7WT)and MCF-7MTA1-shRNA before and after 17β-estradiol ( E2) treatment were examined by Real -time PCR and Western blot respectively .Results The MTA1-shRNA showed maximally 84.9%suppression of MTA1 expression in MCF-7,suggesting a satisfied MTA 1 knockdown cell model was established for subsequent experiments .After treated with E2 for 48 h,MCF-7WT showed an incre-ment of 46%(P〈0.05)and 37%(P〈0.05)of the mRNA and protein level of MMP -9 and a decrement of 32.3%( P〈0.05)and 18.2%(P〈0.05)of TIMP-1;MCF-7MTA1-shRNA showed a decrement of 32.3%(P〈0.05)and 18.2%(P〈0.05)of mRNA and protein expression of MMP -9 respectively but no significant differ-ence in TIMP-1 comparing with MCF-7WT before treated with Estradiol.After E2 treatment,MCF-7MTA1-shRNA didn′t show significant change of MMP -9 except decrements of 32.3%(P〈0.05)and 18.2%(P〈0.05)in the mRNA and protein levels of TIMP -1.Conclusion MTA1 may be involved in the pathway by which estrogen regulated the expression of MMP -9 but not TIMP-1 in ER positive breast cancer cells .
Keywords:Breast cancer  Estrogen  Metastasis - associated protein 1  Matrix metalloproteinase -9  Tis-sue inhibitor of metalloproteinases - 1
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号